Related Experiment Video
Updated: Jun 7, 2026

High-Throughput Expression and Purification of Human Solute Carriers for Structural and Biochemical Studies
Published on: September 29, 2023
The Na(+)/glucose cotransporters: from genes to therapy
R Sabino-Silva1, R C Mori, A David-Silva
1Departamento de Fisiologia e Biofísica, Instituto de Ciências Biomédicas, Universidade de São Paulo, São Paulo, SP, Brasil.
Abstract:
Glucose enters eukaryotic cells via two types of membrane-associated carrier proteins, the Na(+)/glucose cotransporters (SGLT) and the facilitative glucose transporters (GLUT). The SGLT family consists of six members. Among them, the SGLT1 and SGLT2 proteins, encoded by the solute carrier genes SLC5A1 and SLC5A2, respectively, are believed to be the most important ones and have been extensively explored in studies focusing on glucose fluxes under both physiological and pathological conditions. This review considers the regulation of the expression of the SGLT promoted by protein kinases and transcription factors, as well as the alterations determined by diets of different compositions and by pathologies such as diabetes. It also considers congenital defects of sugar metabolism caused by aberrant expression of the SGLT1 in glucose-galactose malabsorption and the SGLT2 in familial renal glycosuria. Finally, it covers some pharmacological compounds that are being currently studied focusing on the interest of controlling glycemia by antagonizing SGLT in renal and intestinal tissues.
Insights
This review explores sodium-glucose cotransporter (SGLT) regulation, focusing on SGLT1 and SGLT2. It covers how diets, diabetes, and genetic defects impact SGLT function and potential drug targets for glycemic control.
Area of Science:
- Cell Biology
- Physiology
- Genetics
Background:
- Glucose transport into eukaryotic cells occurs via Na(+)/glucose cotransporters (SGLT) and facilitative glucose transporters (GLUT).
- The SGLT family includes six members, with SGLT1 and SGLT2 (encoded by SLC5A1 and SLC5A2) being the most studied for glucose transport regulation in health and disease.
Purpose of the Study:
- To review the regulation of SGLT expression by protein kinases and transcription factors.
- To examine how diet composition and pathologies like diabetes alter SGLT function.
- To discuss genetic disorders related to SGLT1 and SGLT2 dysfunction and explore pharmacological strategies targeting SGLT for glycemic control.
Main Methods:
- Literature review of studies on SGLT regulation, function, and related pathologies.
- Analysis of research on protein kinase and transcription factor effects on SGLT expression.
- Examination of dietary and disease-induced alterations in SGLT activity.
- Review of genetic defects and pharmacological interventions targeting SGLT.
Main Results:
- SGLT expression is modulated by protein kinases and transcription factors.
- Dietary factors and diabetes significantly impact SGLT function.
- Aberrant SGLT1 and SGLT2 expression cause glucose-galactose malabsorption and familial renal glycosuria, respectively.
- Antagonizing SGLT in the kidney and intestine is a promising strategy for glycemic control.
Conclusions:
- SGLT proteins play critical roles in glucose homeostasis.
- Dysregulation of SGLT1 and SGLT2 contributes to metabolic disorders and genetic conditions.
- Targeting SGLT offers therapeutic potential for managing hyperglycemia.
Related Concept Videos
Secondary Active Transport
Secondary Active Transport
Secondary Active Transport
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Membrane Proteins
Membrane Transporters
Transporters are mainly composed of alpha-helices, built from bundles of ten or more helices traversing the plasma membrane. The solute-binding sites are located midway, where some of the helices are broken or distorted, making space for the binding site through...

